Record worldwide prodisc® Total Disc Replacement (TDR) revenue nearing $21 million in Q1 2024, growing 47% over prior year. Record worldwide prodisc Cervical TDR revenue of $13.3 million in Q1 … Continue Reading Centinel Spine® Hits Another Revenue Record in First Quarter 2024 as prodisc® Total Disc Replacement Worldwide Growth Momentum Continues
Centinel Spine® exceeds 5,000 U.S. procedures since limited release of prodisc® C Vivo and prodisc C SK in Q4 2022. Centinel Spine’s U.S. prodisc cervical business grew almost 90% in … Continue Reading Over 5,000 Procedures Completed in U.S. with Centinel Spine’s prodisc® C Vivo and prodisc C SK Cervical Total Disc Replacement System
“Centinel Spine is uniquely positioned as the only company that has a device that can treat every type of endplate. Every patient’s anatomy is different, and to have the option … Continue Reading Centinel Spine in the News: Dr. Ross Jones Shows Disc Replacement Not Just “One Size Fits All” Any Longer
This live webinar symposium is open to all spine surgeons worldwide and led by an internationally esteemed group of total disc replacement (TDR) experts. The event will be broadcast from … Continue Reading Centinel Spine® to Sponsor Major Worldwide Live Webinar Symposium on Cervical Disc Arthroplasty
Effective March 1, 2024, the largest commercial payer in the state of Washington—representing almost 2.3 million covered lives—has established positive coverage for one-level lumbar total disc replacement (TDR) procedures, which … Continue Reading Coverage Momentum Continues for Lumbar Total Disc Replacement as the Top Commercial Payer in Washington Establishes Positive Coverage
The largest commercial payer in Tennessee, representing 2.3 million covered lives, has established positive coverage—effective March 1, 2024—for both one- and two-level lumbar total disc replacement (TDR) procedures, which includes prodisc® L. … Continue Reading Coverage Expansion Continues for One- and Two-level Lumbar Total Disc Replacement as the Top Commercial Payer in Tennessee Establishes Positive Coverage for Centinel Spine’s prodisc® L
Source: Becker’s ASC Review Medical device company Centinel Spine saw its prodisc® total disc replacement sales grow 56% in the ASC setting between 2022 and 2023. prodisc sales overall were … Continue Reading Centinel Spine in the News: ASC Sales Boom as Spine Procedures Migrate
Full year 2023 prodisc® Total Disc Replacement (TDR) revenue of nearly $70 million in sales, representing record growth of 55% over prior year. Full-year 2023 prodisc TDR sales broke records … Continue Reading Centinel Spine® Record prodisc® Total Disc Replacement Growth of 55% in 2023 Sets the Foundation for Continued Growth in 2024 and Beyond
Record worldwide prodisc® Total Disc Replacement (TDR) revenue of approximately $7.6 million in December 2023, growing 66% over prior year and representing the first month in Company history with sales … Continue Reading Centinel Spine® Concludes Transformative Year with Record prodisc® Total Disc Replacement Revenue and Growth in December and Fourth Quarter 2023
2023 was a big year for lumbar total disc replacement and prodisc® L coverage expansion. Here’s a roundup of several posts from the last 12 months: Aetna® Updates Disc Replacement … Continue Reading 2023 was a Big Year for prodisc® L Coverage Expansion
Source: BONEZONE … Research has backed motion preservation as a viable — and potentially superior — alternative to fusion. “When you immobilize part of the spinal column that’s meant to … Continue Reading Centinel Spine in the News: Motion Preservation is the Next Big Thing in Spine Surgery
The largest commercial payers in Illinois, Texas, New Mexico, and Oklahoma have adopted Carleon’s Clinical Appropriateness Guidelines-Musculoskeletal Spine Surgery Criteria, which deems one- and two-level lumbar total disc replacement (TDR) … Continue Reading Largest Commercial Payers in Four States Expand Patient Access to Centinel Spine’s prodisc® L
Third quarter 2023 U.S. prodisc® Total Disc Replacement (TDR) revenue approached $14 million in sales—a new record—exceeding second quarter 2023, the company’s previous best quarter. Third quarter 2023 worldwide prodisc … Continue Reading Centinel Spine® Worldwide prodisc® Total Disc Replacement Momentum Continues in Third Quarter 2023 with 61% Year-over-Year Growth
The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as … Continue Reading Centinel Spine® PMA Application for First-of-its-Kind 2-Level prodisc® C Vivo and prodisc C SK Match-the-Disc™ Cervical Total Disc Replacement System Filed and Proceeding with Substantive Review
The completed transaction includes the sale of all cervical and lumbar fusion products, including the STALIF® technology platform. In divesting its fusion portfolio, Centinel Spine will focus exclusively on its … Continue Reading Centinel Spine® Completes Divestment of its Spine Fusion Business to Silony Spine
Centinel Spine is the only company to offer cervical and lumbar total disc replacement (TDR) systems that allow matching the disc to the needs of the patient and surgeon. Centinel … Continue Reading Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc® Match-the-Disc™ Cervical and Lumbar Total Disc Replacement Systems